Table 1 Patient characteristics
Characteristics | All (n = 121) | Crystalloid -only regimen (n = 65) | Magnesium –supplemented regimen (n = 56) | P value | |
|---|---|---|---|---|---|
Age | Median (range) | 62 (28–78) | 62 (28–77) | 62 (42–78) | 0.2943† |
Sex | Male | 102 | 52 | 50 | 0.1616* |
Female | 19 | 13 | 6 | ||
BSA (m2) | Median (range) | 1.63 (1.27–2.00) | 1.59 (1.33–1.96) | 1.65 (1.27–2.00) | 0.2542† |
PS | 0 / 1 / 2 | 67 / 46 / 8 | 38 / 22 / 5 | 29 / 24 / 3 | 0.5676* |
Primary Site | Nasal cavity and Paranasal sinuses | 15 | 14 | 1 | 0.0001* |
Oral cavity | 4 | 4 | 0 | ||
Nasopharynx | 1 | 0 | 1 | ||
Oropharynx | 40 | 15 | 25 | ||
Hypopharynx | 32 | 18 | 14 | ||
Laryynx | 8 | 1 | 7 | ||
Cervical esophagus | 13 | 7 | 6 | ||
Unknown | 8 | 6 | 2 | ||
Creatine (mg/dL) | Median (range) | 0.71 (0.38–1.07) | 0.69 (0.38–1.07) | 0.73 (0.51–1.07) | 0.1152† |
Ccr (m L/min) | Median (range) | 89.1 (54.5–186.7) | 79.1 (54.5–156.1) | 89.1 (57.0–143.6) | 0.1712† |
Albumin (g/mL) | Median (range) | 4.1 (2.9–5.1) | 4.1 (3.0–5.0) | 4.2 (2.9–5.1) | 0.1081† |
Hematocrit (%) | Median (range) | 39.7 (26.6–50.8) | 39.1 (26.6–50.8) | 40.4 (31.3–48.6) | 0.1001† |
Aprepitant | Administration | 78 | 22 | 56 | < 0.0001† |